Calidi Biotherapeutics, Inc. — Institutional Ownership
Which tracked institutions hold CLDI, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
4
Funds holding
$6751
Total value held
Buying
3 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Northern Trust Corp | $4241 | 17758 | — | Held |
| 2 | Morgan Stanley | $2261 | 9467 | +8000 | +545.33% |
| 3 | Jpmorgan Chase & Co | $248 | 1042 | — | NEW BUY |
| 4 | Citigroup Inc | $1 | 1 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.